Serial Number | 97198644 |
Word Mark | R |
Filing Date | Friday, December 31, 2021 |
Status | 700 - REGISTERED |
Status Date | Tuesday, January 24, 2023 |
Registration Number | 6963961 |
Registration Date | Tuesday, January 24, 2023 |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, November 8, 2022 |
Description of Mark | The mark consists of a stylized letter "R" sharing a stroke "|" with a stylized upside-down inverted "R", where the stylized letter "R" has two openings between the stroke "|" and the right part of "R" and the stylized upside-down inverted "R" has two openings between the stroke "|" and the left part of the upside-down inverted "R". |
Pseudo Mark | R R |
Pseudo Mark | RR |
Pseudo Mark | REVIR |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consultancy services in the field of research and development of therapies and medical preparations; Provision of scientific expertise in the nature of scientific study and research in the field of medicine; Scientific research and development for medical and veterinary purposes; Medical and scientific research in the field of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease, metabolic diseases; Providing medical and scientific research information, consultancy, and advisory services in the fields of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease; Compiling data for medical and scientific research, clinical trials, and drug admission |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, January 5, 2022 |
Primary Code | 042 |
First Use Anywhere Date | Monday, May 10, 2021 |
First Use In Commerce Date | Monday, May 10, 2021 |
Party Name | Revir Therapeutics, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Foster City, CA 94404 |
Party Name | Revir Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Foster City, CA 94404 |
Party Name | Revir Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Foster City, CA 94404 |
Event Date | Event Description |
Tuesday, January 24, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, January 24, 2023 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, November 8, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 8, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, October 19, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, October 5, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, October 5, 2022 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, October 5, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, October 5, 2022 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, October 5, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, October 4, 2022 | ASSIGNED TO EXAMINER |
Thursday, September 1, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, September 1, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Thursday, September 1, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, September 1, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, January 5, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, January 4, 2022 | NEW APPLICATION ENTERED |